nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazepam—ALB—Acitretin—psoriasis	0.045	0.0629	CbGbCtD
Diazepam—CYP2C8—Tazarotene—psoriasis	0.044	0.0615	CbGbCtD
Diazepam—CYP3A5—Beclomethasone—psoriasis	0.0425	0.0595	CbGbCtD
Diazepam—CYP1A2—Clobetasol propionate—psoriasis	0.0418	0.0584	CbGbCtD
Diazepam—CYP2B6—Cholecalciferol—psoriasis	0.0248	0.0347	CbGbCtD
Diazepam—CYP1A2—Methoxsalen—psoriasis	0.0219	0.0307	CbGbCtD
Diazepam—ALB—Mycophenolate mofetil—psoriasis	0.0211	0.0295	CbGbCtD
Diazepam—CYP2C8—Cholecalciferol—psoriasis	0.0188	0.0263	CbGbCtD
Diazepam—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0181	0.0253	CbGbCtD
Diazepam—CYP3A7—Hydrocortisone—psoriasis	0.0181	0.0253	CbGbCtD
Diazepam—CYP3A7—Cyclosporine—psoriasis	0.0171	0.0239	CbGbCtD
Diazepam—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0171	0.0239	CbGbCtD
Diazepam—CYP3A5—Mycophenolate mofetil—psoriasis	0.0169	0.0237	CbGbCtD
Diazepam—ALB—Prednisone—psoriasis	0.0168	0.0235	CbGbCtD
Diazepam—CYP2C8—Mycophenolate mofetil—psoriasis	0.0163	0.0228	CbGbCtD
Diazepam—CYP2C19—Cholecalciferol—psoriasis	0.0157	0.022	CbGbCtD
Diazepam—CYP3A4—Calcitriol—psoriasis	0.0148	0.0207	CbGbCtD
Diazepam—CYP3A5—Hydrocortisone—psoriasis	0.0136	0.019	CbGbCtD
Diazepam—CYP2C9—Cholecalciferol—psoriasis	0.0131	0.0183	CbGbCtD
Diazepam—CYP2C8—Hydrocortisone—psoriasis	0.0131	0.0183	CbGbCtD
Diazepam—CYP3A5—Cyclosporine—psoriasis	0.0128	0.0179	CbGbCtD
Diazepam—CYP2C8—Cyclosporine—psoriasis	0.0123	0.0172	CbGbCtD
Diazepam—CYP3A4—Methoxsalen—psoriasis	0.0115	0.0161	CbGbCtD
Diazepam—CYP3A7—Dexamethasone—psoriasis	0.0113	0.0157	CbGbCtD
Diazepam—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0113	0.0157	CbGbCtD
Diazepam—ABCB1—Mycophenolate mofetil—psoriasis	0.011	0.0154	CbGbCtD
Diazepam—CYP2C19—Prednisone—psoriasis	0.0109	0.0153	CbGbCtD
Diazepam—CYP2E1—Dexamethasone—psoriasis	0.0109	0.0152	CbGbCtD
Diazepam—CYP2B6—Dexamethasone—psoriasis	0.0107	0.015	CbGbCtD
Diazepam—CYP2C19—Cyclosporine—psoriasis	0.0103	0.0145	CbGbCtD
Diazepam—ABCB1—Betamethasone—psoriasis	0.00945	0.0132	CbGbCtD
Diazepam—ABCB1—Prednisolone—psoriasis	0.00933	0.013	CbGbCtD
Diazepam—ABCB1—Hydrocortisone—psoriasis	0.00884	0.0124	CbGbCtD
Diazepam—ABCB1—Prednisone—psoriasis	0.00881	0.0123	CbGbCtD
Diazepam—CYP2C9—Cyclosporine—psoriasis	0.0086	0.012	CbGbCtD
Diazepam—CYP3A5—Dexamethasone—psoriasis	0.00845	0.0118	CbGbCtD
Diazepam—ALB—Methotrexate—psoriasis	0.00845	0.0118	CbGbCtD
Diazepam—ABCB1—Cyclosporine—psoriasis	0.00835	0.0117	CbGbCtD
Diazepam—CYP2C8—Dexamethasone—psoriasis	0.00812	0.0114	CbGbCtD
Diazepam—CYP3A4—Cholecalciferol—psoriasis	0.00761	0.0106	CbGbCtD
Diazepam—CYP2C19—Dexamethasone—psoriasis	0.00682	0.00953	CbGbCtD
Diazepam—CYP3A4—Mycophenolate mofetil—psoriasis	0.0066	0.00923	CbGbCtD
Diazepam—CYP3A4—Triamcinolone—psoriasis	0.0066	0.00923	CbGbCtD
Diazepam—CYP2C9—Dexamethasone—psoriasis	0.00567	0.00792	CbGbCtD
Diazepam—CYP3A4—Betamethasone—psoriasis	0.00566	0.00792	CbGbCtD
Diazepam—CYP3A4—Prednisolone—psoriasis	0.00559	0.00781	CbGbCtD
Diazepam—ABCB1—Dexamethasone—psoriasis	0.0055	0.00769	CbGbCtD
Diazepam—CYP3A4—Hydrocortisone—psoriasis	0.0053	0.00741	CbGbCtD
Diazepam—CYP3A4—Prednisone—psoriasis	0.00528	0.00738	CbGbCtD
Diazepam—CYP3A4—Cyclosporine—psoriasis	0.005	0.007	CbGbCtD
Diazepam—ABCB1—Methotrexate—psoriasis	0.00442	0.00618	CbGbCtD
Diazepam—CYP3A4—Dexamethasone—psoriasis	0.00329	0.00461	CbGbCtD
Diazepam—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000144	0.00366	CbGpPWpGaD
Diazepam—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000142	0.00362	CbGpPWpGaD
Diazepam—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000142	0.00361	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000134	0.00342	CbGpPWpGaD
Diazepam—CYP2C18—FOXA1 transcription factor network—JUN—psoriasis	0.000129	0.00327	CbGpPWpGaD
Diazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000126	0.0032	CbGpPWpGaD
Diazepam—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000125	0.00317	CbGpPWpGaD
Diazepam—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000124	0.00316	CbGpPWpGaD
Diazepam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000124	0.00316	CbGpPWpGaD
Diazepam—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000123	0.00313	CbGpPWpGaD
Diazepam—PTGS1—Overview of nanoparticle effects—TNF—psoriasis	0.000121	0.00309	CbGpPWpGaD
Diazepam—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.00012	0.00304	CbGpPWpGaD
Diazepam—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000117	0.00297	CbGpPWpGaD
Diazepam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000116	0.00295	CbGpPWpGaD
Diazepam—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000111	0.00283	CbGpPWpGaD
Diazepam—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.00011	0.00279	CbGpPWpGaD
Diazepam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000109	0.00278	CbGpPWpGaD
Diazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000108	0.00275	CbGpPWpGaD
Diazepam—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000108	0.00274	CbGpPWpGaD
Diazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000107	0.00273	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—IL13—psoriasis	0.000106	0.0027	CbGpPWpGaD
Diazepam—Insomnia—Prednisolone—psoriasis	0.000106	0.000431	CcSEcCtD
Diazepam—Hepatobiliary disease—Methotrexate—psoriasis	0.000105	0.00043	CcSEcCtD
Diazepam—Gastrointestinal pain—Cyclosporine—psoriasis	0.000105	0.000429	CcSEcCtD
Diazepam—Loss of consciousness—Dexamethasone—psoriasis	0.000105	0.000429	CcSEcCtD
Diazepam—Loss of consciousness—Betamethasone—psoriasis	0.000105	0.000429	CcSEcCtD
Diazepam—Dizziness—Mycophenolic acid—psoriasis	0.000105	0.000428	CcSEcCtD
Diazepam—Paraesthesia—Prednisolone—psoriasis	0.000105	0.000428	CcSEcCtD
Diazepam—Tachycardia—Triamcinolone—psoriasis	0.000105	0.000428	CcSEcCtD
Diazepam—Mental disorder—Prednisone—psoriasis	0.000105	0.000427	CcSEcCtD
Diazepam—Erythema—Prednisone—psoriasis	0.000104	0.000425	CcSEcCtD
Diazepam—Malnutrition—Prednisone—psoriasis	0.000104	0.000425	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000104	0.000424	CcSEcCtD
Diazepam—Hyperhidrosis—Triamcinolone—psoriasis	0.000104	0.000424	CcSEcCtD
Diazepam—Agranulocytosis—Methotrexate—psoriasis	0.000104	0.000424	CcSEcCtD
Diazepam—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000103	0.000421	CcSEcCtD
Diazepam—Insomnia—Hydrocortisone—psoriasis	0.000103	0.000421	CcSEcCtD
Diazepam—Paraesthesia—Hydrocortisone—psoriasis	0.000103	0.000418	CcSEcCtD
Diazepam—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000103	0.000418	CcSEcCtD
Diazepam—Urticaria—Cyclosporine—psoriasis	0.000102	0.000416	CcSEcCtD
Diazepam—Myalgia—Dexamethasone—psoriasis	0.000102	0.000415	CcSEcCtD
Diazepam—Myalgia—Betamethasone—psoriasis	0.000102	0.000415	CcSEcCtD
Diazepam—Abdominal pain—Cyclosporine—psoriasis	0.000102	0.000414	CcSEcCtD
Diazepam—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000101	0.00258	CbGpPWpGaD
Diazepam—Vomiting—Mycophenolic acid—psoriasis	0.000101	0.000412	CcSEcCtD
Diazepam—Discomfort—Betamethasone—psoriasis	0.000101	0.00041	CcSEcCtD
Diazepam—Discomfort—Dexamethasone—psoriasis	0.000101	0.00041	CcSEcCtD
Diazepam—Dyspepsia—Hydrocortisone—psoriasis	0.000101	0.00041	CcSEcCtD
Diazepam—Rash—Mycophenolic acid—psoriasis	0.0001	0.000409	CcSEcCtD
Diazepam—Dermatitis—Mycophenolic acid—psoriasis	0.0001	0.000408	CcSEcCtD
Diazepam—Pain—Prednisolone—psoriasis	0.0001	0.000408	CcSEcCtD
Diazepam—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.0001	0.00254	CbGpPWpGaD
Diazepam—Urticaria—Mycophenolate mofetil—psoriasis	9.97e-05	0.000406	CcSEcCtD
Diazepam—Headache—Mycophenolic acid—psoriasis	9.97e-05	0.000406	CcSEcCtD
Diazepam—Decreased appetite—Hydrocortisone—psoriasis	9.94e-05	0.000405	CcSEcCtD
Diazepam—Abdominal pain—Mycophenolate mofetil—psoriasis	9.92e-05	0.000404	CcSEcCtD
Diazepam—PTGS1—Selenium Micronutrient Network—CAT—psoriasis	9.91e-05	0.00252	CbGpPWpGaD
Diazepam—Urinary tract disorder—Methotrexate—psoriasis	9.89e-05	0.000403	CcSEcCtD
Diazepam—Gastrointestinal disorder—Hydrocortisone—psoriasis	9.87e-05	0.000402	CcSEcCtD
Diazepam—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	9.87e-05	0.00251	CbGpPWpGaD
Diazepam—Fatigue—Hydrocortisone—psoriasis	9.86e-05	0.000402	CcSEcCtD
Diazepam—Vision blurred—Prednisone—psoriasis	9.83e-05	0.0004	CcSEcCtD
Diazepam—Urethral disorder—Methotrexate—psoriasis	9.81e-05	0.0004	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Triamcinolone—psoriasis	9.81e-05	0.0004	CcSEcCtD
Diazepam—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	9.8e-05	0.00249	CbGpPWpGaD
Diazepam—Pain—Hydrocortisone—psoriasis	9.78e-05	0.000398	CcSEcCtD
Diazepam—Anaphylactic shock—Betamethasone—psoriasis	9.77e-05	0.000398	CcSEcCtD
Diazepam—Anaphylactic shock—Dexamethasone—psoriasis	9.77e-05	0.000398	CcSEcCtD
Diazepam—Insomnia—Triamcinolone—psoriasis	9.74e-05	0.000397	CcSEcCtD
Diazepam—Infection—Dexamethasone—psoriasis	9.71e-05	0.000395	CcSEcCtD
Diazepam—Infection—Betamethasone—psoriasis	9.71e-05	0.000395	CcSEcCtD
Diazepam—Paraesthesia—Triamcinolone—psoriasis	9.67e-05	0.000394	CcSEcCtD
Diazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	9.66e-05	0.00246	CbGpPWpGaD
Diazepam—Feeling abnormal—Prednisolone—psoriasis	9.65e-05	0.000393	CcSEcCtD
Diazepam—Visual impairment—Methotrexate—psoriasis	9.65e-05	0.000393	CcSEcCtD
Diazepam—Anaemia—Prednisone—psoriasis	9.64e-05	0.000393	CcSEcCtD
Diazepam—Shock—Betamethasone—psoriasis	9.61e-05	0.000392	CcSEcCtD
Diazepam—Shock—Dexamethasone—psoriasis	9.61e-05	0.000392	CcSEcCtD
Diazepam—Dyspnoea—Triamcinolone—psoriasis	9.6e-05	0.000391	CcSEcCtD
Diazepam—Nervous system disorder—Betamethasone—psoriasis	9.58e-05	0.00039	CcSEcCtD
Diazepam—Nervous system disorder—Dexamethasone—psoriasis	9.58e-05	0.00039	CcSEcCtD
Diazepam—Agitation—Prednisone—psoriasis	9.58e-05	0.00039	CcSEcCtD
Diazepam—Thrombocytopenia—Betamethasone—psoriasis	9.57e-05	0.00039	CcSEcCtD
Diazepam—Thrombocytopenia—Dexamethasone—psoriasis	9.57e-05	0.00039	CcSEcCtD
Diazepam—ALB—Hemostasis—SERPINB8—psoriasis	9.54e-05	0.00243	CbGpPWpGaD
Diazepam—Tachycardia—Betamethasone—psoriasis	9.54e-05	0.000388	CcSEcCtD
Diazepam—Tachycardia—Dexamethasone—psoriasis	9.54e-05	0.000388	CcSEcCtD
Diazepam—Hypersensitivity—Cyclosporine—psoriasis	9.48e-05	0.000386	CcSEcCtD
Diazepam—Dyspepsia—Triamcinolone—psoriasis	9.48e-05	0.000386	CcSEcCtD
Diazepam—Nausea—Mycophenolic acid—psoriasis	9.45e-05	0.000385	CcSEcCtD
Diazepam—Hyperhidrosis—Betamethasone—psoriasis	9.45e-05	0.000385	CcSEcCtD
Diazepam—Hyperhidrosis—Dexamethasone—psoriasis	9.45e-05	0.000385	CcSEcCtD
Diazepam—Feeling abnormal—Hydrocortisone—psoriasis	9.42e-05	0.000384	CcSEcCtD
Diazepam—Vertigo—Prednisone—psoriasis	9.37e-05	0.000382	CcSEcCtD
Diazepam—Eye disorder—Methotrexate—psoriasis	9.35e-05	0.000381	CcSEcCtD
Diazepam—Gastrointestinal pain—Hydrocortisone—psoriasis	9.35e-05	0.000381	CcSEcCtD
Diazepam—Syncope—Prednisone—psoriasis	9.35e-05	0.000381	CcSEcCtD
Diazepam—Anorexia—Dexamethasone—psoriasis	9.31e-05	0.000379	CcSEcCtD
Diazepam—Anorexia—Betamethasone—psoriasis	9.31e-05	0.000379	CcSEcCtD
Diazepam—Urticaria—Prednisolone—psoriasis	9.3e-05	0.000379	CcSEcCtD
Diazepam—Cardiac disorder—Methotrexate—psoriasis	9.29e-05	0.000378	CcSEcCtD
Diazepam—Fatigue—Triamcinolone—psoriasis	9.28e-05	0.000378	CcSEcCtD
Diazepam—Hypersensitivity—Mycophenolate mofetil—psoriasis	9.25e-05	0.000377	CcSEcCtD
Diazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.25e-05	0.00235	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—HLA-C—psoriasis	9.23e-05	0.00235	CbGpPWpGaD
Diazepam—Asthenia—Cyclosporine—psoriasis	9.23e-05	0.000376	CcSEcCtD
Diazepam—Pain—Triamcinolone—psoriasis	9.21e-05	0.000375	CcSEcCtD
Diazepam—ABCB1—Allograft Rejection—IL13—psoriasis	9.18e-05	0.00233	CbGpPWpGaD
Diazepam—Loss of consciousness—Prednisone—psoriasis	9.16e-05	0.000373	CcSEcCtD
Diazepam—Hypotension—Dexamethasone—psoriasis	9.13e-05	0.000372	CcSEcCtD
Diazepam—Hypotension—Betamethasone—psoriasis	9.13e-05	0.000372	CcSEcCtD
Diazepam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	9.11e-05	0.00232	CbGpPWpGaD
Diazepam—Pruritus—Cyclosporine—psoriasis	9.1e-05	0.000371	CcSEcCtD
Diazepam—Urticaria—Hydrocortisone—psoriasis	9.09e-05	0.00037	CcSEcCtD
Diazepam—Angiopathy—Methotrexate—psoriasis	9.08e-05	0.00037	CcSEcCtD
Diazepam—Abdominal pain—Hydrocortisone—psoriasis	9.04e-05	0.000368	CcSEcCtD
Diazepam—Asthenia—Mycophenolate mofetil—psoriasis	9.01e-05	0.000367	CcSEcCtD
Diazepam—Chills—Methotrexate—psoriasis	8.98e-05	0.000366	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.9e-05	0.000363	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Betamethasone—psoriasis	8.9e-05	0.000363	CcSEcCtD
Diazepam—Pruritus—Mycophenolate mofetil—psoriasis	8.88e-05	0.000362	CcSEcCtD
Diazepam—Arthralgia—Prednisone—psoriasis	8.88e-05	0.000362	CcSEcCtD
Diazepam—Myalgia—Prednisone—psoriasis	8.88e-05	0.000362	CcSEcCtD
Diazepam—Feeling abnormal—Triamcinolone—psoriasis	8.87e-05	0.000361	CcSEcCtD
Diazepam—Insomnia—Dexamethasone—psoriasis	8.84e-05	0.00036	CcSEcCtD
Diazepam—Insomnia—Betamethasone—psoriasis	8.84e-05	0.00036	CcSEcCtD
Diazepam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	8.82e-05	0.000359	CcSEcCtD
Diazepam—Diarrhoea—Cyclosporine—psoriasis	8.8e-05	0.000359	CcSEcCtD
Diazepam—Paraesthesia—Dexamethasone—psoriasis	8.77e-05	0.000357	CcSEcCtD
Diazepam—Paraesthesia—Betamethasone—psoriasis	8.77e-05	0.000357	CcSEcCtD
Diazepam—Discomfort—Prednisone—psoriasis	8.77e-05	0.000357	CcSEcCtD
Diazepam—Mental disorder—Methotrexate—psoriasis	8.77e-05	0.000357	CcSEcCtD
Diazepam—Malnutrition—Methotrexate—psoriasis	8.71e-05	0.000355	CcSEcCtD
Diazepam—Erythema—Methotrexate—psoriasis	8.71e-05	0.000355	CcSEcCtD
Diazepam—CYP1A2—Biological oxidations—CYP2S1—psoriasis	8.67e-05	0.0022	CbGpPWpGaD
Diazepam—Hypersensitivity—Prednisolone—psoriasis	8.63e-05	0.000351	CcSEcCtD
Diazepam—Dyspepsia—Betamethasone—psoriasis	8.6e-05	0.00035	CcSEcCtD
Diazepam—Dyspepsia—Dexamethasone—psoriasis	8.6e-05	0.00035	CcSEcCtD
Diazepam—Diarrhoea—Mycophenolate mofetil—psoriasis	8.59e-05	0.00035	CcSEcCtD
Diazepam—Urticaria—Triamcinolone—psoriasis	8.55e-05	0.000348	CcSEcCtD
Diazepam—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	8.55e-05	0.00217	CbGpPWpGaD
Diazepam—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	8.54e-05	0.00217	CbGpPWpGaD
Diazepam—Dysgeusia—Methotrexate—psoriasis	8.53e-05	0.000348	CcSEcCtD
Diazepam—Dizziness—Cyclosporine—psoriasis	8.51e-05	0.000347	CcSEcCtD
Diazepam—Anaphylactic shock—Prednisone—psoriasis	8.51e-05	0.000347	CcSEcCtD
Diazepam—Decreased appetite—Dexamethasone—psoriasis	8.49e-05	0.000346	CcSEcCtD
Diazepam—Decreased appetite—Betamethasone—psoriasis	8.49e-05	0.000346	CcSEcCtD
Diazepam—Infection—Prednisone—psoriasis	8.45e-05	0.000344	CcSEcCtD
Diazepam—ABCB1—Allograft Rejection—IL17A—psoriasis	8.44e-05	0.00215	CbGpPWpGaD
Diazepam—Gastrointestinal disorder—Dexamethasone—psoriasis	8.44e-05	0.000344	CcSEcCtD
Diazepam—Gastrointestinal disorder—Betamethasone—psoriasis	8.44e-05	0.000344	CcSEcCtD
Diazepam—Back pain—Methotrexate—psoriasis	8.43e-05	0.000343	CcSEcCtD
Diazepam—Hypersensitivity—Hydrocortisone—psoriasis	8.43e-05	0.000343	CcSEcCtD
Diazepam—Fatigue—Betamethasone—psoriasis	8.42e-05	0.000343	CcSEcCtD
Diazepam—Fatigue—Dexamethasone—psoriasis	8.42e-05	0.000343	CcSEcCtD
Diazepam—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	8.41e-05	0.00214	CbGpPWpGaD
Diazepam—Shock—Prednisone—psoriasis	8.37e-05	0.000341	CcSEcCtD
Diazepam—Pain—Dexamethasone—psoriasis	8.36e-05	0.00034	CcSEcCtD
Diazepam—Pain—Betamethasone—psoriasis	8.36e-05	0.00034	CcSEcCtD
Diazepam—Nervous system disorder—Prednisone—psoriasis	8.34e-05	0.00034	CcSEcCtD
Diazepam—Tachycardia—Prednisone—psoriasis	8.3e-05	0.000338	CcSEcCtD
Diazepam—Dizziness—Mycophenolate mofetil—psoriasis	8.3e-05	0.000338	CcSEcCtD
Diazepam—Skin disorder—Prednisone—psoriasis	8.27e-05	0.000337	CcSEcCtD
Diazepam—Hyperhidrosis—Prednisone—psoriasis	8.23e-05	0.000335	CcSEcCtD
Diazepam—Vision blurred—Methotrexate—psoriasis	8.21e-05	0.000334	CcSEcCtD
Diazepam—Asthenia—Hydrocortisone—psoriasis	8.21e-05	0.000334	CcSEcCtD
Diazepam—Vomiting—Cyclosporine—psoriasis	8.18e-05	0.000333	CcSEcCtD
Diazepam—Rash—Cyclosporine—psoriasis	8.11e-05	0.00033	CcSEcCtD
Diazepam—Anorexia—Prednisone—psoriasis	8.11e-05	0.00033	CcSEcCtD
Diazepam—Dermatitis—Cyclosporine—psoriasis	8.11e-05	0.00033	CcSEcCtD
Diazepam—Pruritus—Hydrocortisone—psoriasis	8.09e-05	0.00033	CcSEcCtD
Diazepam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.08e-05	0.00205	CbGpPWpGaD
Diazepam—Headache—Cyclosporine—psoriasis	8.06e-05	0.000328	CcSEcCtD
Diazepam—Anaemia—Methotrexate—psoriasis	8.05e-05	0.000328	CcSEcCtD
Diazepam—Feeling abnormal—Betamethasone—psoriasis	8.05e-05	0.000328	CcSEcCtD
Diazepam—Feeling abnormal—Dexamethasone—psoriasis	8.05e-05	0.000328	CcSEcCtD
Diazepam—ALB—Folate Metabolism—CAT—psoriasis	8.01e-05	0.00204	CbGpPWpGaD
Diazepam—Gastrointestinal pain—Betamethasone—psoriasis	7.99e-05	0.000325	CcSEcCtD
Diazepam—Gastrointestinal pain—Dexamethasone—psoriasis	7.99e-05	0.000325	CcSEcCtD
Diazepam—Vomiting—Mycophenolate mofetil—psoriasis	7.98e-05	0.000325	CcSEcCtD
Diazepam—Hypersensitivity—Triamcinolone—psoriasis	7.93e-05	0.000323	CcSEcCtD
Diazepam—Rash—Mycophenolate mofetil—psoriasis	7.92e-05	0.000322	CcSEcCtD
Diazepam—Dermatitis—Mycophenolate mofetil—psoriasis	7.91e-05	0.000322	CcSEcCtD
Diazepam—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	7.87e-05	0.002	CbGpPWpGaD
Diazepam—Headache—Mycophenolate mofetil—psoriasis	7.86e-05	0.00032	CcSEcCtD
Diazepam—ABCB1—Allograft Rejection—IL12B—psoriasis	7.85e-05	0.002	CbGpPWpGaD
Diazepam—Vertigo—Methotrexate—psoriasis	7.83e-05	0.000319	CcSEcCtD
Diazepam—Diarrhoea—Hydrocortisone—psoriasis	7.83e-05	0.000319	CcSEcCtD
Diazepam—ALB—Vitamin B12 Metabolism—CRP—psoriasis	7.82e-05	0.00199	CbGpPWpGaD
Diazepam—Leukopenia—Methotrexate—psoriasis	7.8e-05	0.000318	CcSEcCtD
Diazepam—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	7.77e-05	0.00198	CbGpPWpGaD
Diazepam—Urticaria—Dexamethasone—psoriasis	7.76e-05	0.000316	CcSEcCtD
Diazepam—Urticaria—Betamethasone—psoriasis	7.76e-05	0.000316	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Prednisone—psoriasis	7.75e-05	0.000316	CcSEcCtD
Diazepam—Dizziness—Prednisolone—psoriasis	7.74e-05	0.000315	CcSEcCtD
Diazepam—Asthenia—Triamcinolone—psoriasis	7.73e-05	0.000315	CcSEcCtD
Diazepam—Abdominal pain—Dexamethasone—psoriasis	7.72e-05	0.000315	CcSEcCtD
Diazepam—Abdominal pain—Betamethasone—psoriasis	7.72e-05	0.000315	CcSEcCtD
Diazepam—Insomnia—Prednisone—psoriasis	7.7e-05	0.000313	CcSEcCtD
Diazepam—ABCB1—Allograft Rejection—HLA-E—psoriasis	7.66e-05	0.00195	CbGpPWpGaD
Diazepam—GABRR1—Transmembrane transport of small molecules—CP—psoriasis	7.66e-05	0.00195	CbGpPWpGaD
Diazepam—ALB—Vitamin B12 Metabolism—APOE—psoriasis	7.65e-05	0.00195	CbGpPWpGaD
Diazepam—Nausea—Cyclosporine—psoriasis	7.64e-05	0.000311	CcSEcCtD
Diazepam—Paraesthesia—Prednisone—psoriasis	7.64e-05	0.000311	CcSEcCtD
Diazepam—Pruritus—Triamcinolone—psoriasis	7.62e-05	0.00031	CcSEcCtD
Diazepam—Cough—Methotrexate—psoriasis	7.6e-05	0.00031	CcSEcCtD
Diazepam—Dizziness—Hydrocortisone—psoriasis	7.56e-05	0.000308	CcSEcCtD
Diazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.54e-05	0.00192	CbGpPWpGaD
Diazepam—Dyspepsia—Prednisone—psoriasis	7.49e-05	0.000305	CcSEcCtD
Diazepam—CYP1A2—Tryptophan metabolism—CAT—psoriasis	7.48e-05	0.0019	CbGpPWpGaD
Diazepam—Nausea—Mycophenolate mofetil—psoriasis	7.46e-05	0.000304	CcSEcCtD
Diazepam—Myalgia—Methotrexate—psoriasis	7.42e-05	0.000302	CcSEcCtD
Diazepam—Arthralgia—Methotrexate—psoriasis	7.42e-05	0.000302	CcSEcCtD
Diazepam—Decreased appetite—Prednisone—psoriasis	7.4e-05	0.000301	CcSEcCtD
Diazepam—Rash—Prednisolone—psoriasis	7.38e-05	0.000301	CcSEcCtD
Diazepam—Dermatitis—Prednisolone—psoriasis	7.38e-05	0.0003	CcSEcCtD
Diazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	7.37e-05	0.0003	CcSEcCtD
Diazepam—ALB—Folate Metabolism—IL4—psoriasis	7.36e-05	0.00187	CbGpPWpGaD
Diazepam—Fatigue—Prednisone—psoriasis	7.34e-05	0.000299	CcSEcCtD
Diazepam—Headache—Prednisolone—psoriasis	7.34e-05	0.000299	CcSEcCtD
Diazepam—Discomfort—Methotrexate—psoriasis	7.33e-05	0.000299	CcSEcCtD
Diazepam—GABRQ—Transmembrane transport of small molecules—CP—psoriasis	7.3e-05	0.00186	CbGpPWpGaD
Diazepam—GABRR2—Transmembrane transport of small molecules—CP—psoriasis	7.3e-05	0.00186	CbGpPWpGaD
Diazepam—GABRR1—Transmembrane transport of small molecules—CARM1—psoriasis	7.3e-05	0.00186	CbGpPWpGaD
Diazepam—Constipation—Prednisone—psoriasis	7.28e-05	0.000296	CcSEcCtD
Diazepam—Vomiting—Hydrocortisone—psoriasis	7.27e-05	0.000296	CcSEcCtD
Diazepam—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	7.23e-05	0.00184	CbGpPWpGaD
Diazepam—Rash—Hydrocortisone—psoriasis	7.21e-05	0.000294	CcSEcCtD
Diazepam—Dermatitis—Hydrocortisone—psoriasis	7.2e-05	0.000293	CcSEcCtD
Diazepam—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	7.19e-05	0.00183	CbGpPWpGaD
Diazepam—Confusional state—Methotrexate—psoriasis	7.17e-05	0.000292	CcSEcCtD
Diazepam—Headache—Hydrocortisone—psoriasis	7.16e-05	0.000292	CcSEcCtD
Diazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.14e-05	0.00181	CbGpPWpGaD
Diazepam—Dizziness—Triamcinolone—psoriasis	7.12e-05	0.00029	CcSEcCtD
Diazepam—Anaphylactic shock—Methotrexate—psoriasis	7.11e-05	0.00029	CcSEcCtD
Diazepam—Infection—Methotrexate—psoriasis	7.07e-05	0.000288	CcSEcCtD
Diazepam—Feeling abnormal—Prednisone—psoriasis	7.01e-05	0.000286	CcSEcCtD
Diazepam—Asthenia—Betamethasone—psoriasis	7.01e-05	0.000286	CcSEcCtD
Diazepam—Asthenia—Dexamethasone—psoriasis	7.01e-05	0.000286	CcSEcCtD
Diazepam—Nervous system disorder—Methotrexate—psoriasis	6.97e-05	0.000284	CcSEcCtD
Diazepam—GABRQ—Transmembrane transport of small molecules—CARM1—psoriasis	6.97e-05	0.00177	CbGpPWpGaD
Diazepam—GABRR2—Transmembrane transport of small molecules—CARM1—psoriasis	6.97e-05	0.00177	CbGpPWpGaD
Diazepam—Thrombocytopenia—Methotrexate—psoriasis	6.96e-05	0.000284	CcSEcCtD
Diazepam—Gastrointestinal pain—Prednisone—psoriasis	6.96e-05	0.000283	CcSEcCtD
Diazepam—Nausea—Prednisolone—psoriasis	6.96e-05	0.000283	CcSEcCtD
Diazepam—Pruritus—Dexamethasone—psoriasis	6.91e-05	0.000282	CcSEcCtD
Diazepam—Pruritus—Betamethasone—psoriasis	6.91e-05	0.000282	CcSEcCtD
Diazepam—Skin disorder—Methotrexate—psoriasis	6.91e-05	0.000281	CcSEcCtD
Diazepam—Hyperhidrosis—Methotrexate—psoriasis	6.87e-05	0.00028	CcSEcCtD
Diazepam—Vomiting—Triamcinolone—psoriasis	6.85e-05	0.000279	CcSEcCtD
Diazepam—Nausea—Hydrocortisone—psoriasis	6.79e-05	0.000277	CcSEcCtD
Diazepam—Rash—Triamcinolone—psoriasis	6.79e-05	0.000277	CcSEcCtD
Diazepam—Dermatitis—Triamcinolone—psoriasis	6.78e-05	0.000276	CcSEcCtD
Diazepam—Anorexia—Methotrexate—psoriasis	6.78e-05	0.000276	CcSEcCtD
Diazepam—Urticaria—Prednisone—psoriasis	6.76e-05	0.000275	CcSEcCtD
Diazepam—Headache—Triamcinolone—psoriasis	6.75e-05	0.000275	CcSEcCtD
Diazepam—Abdominal pain—Prednisone—psoriasis	6.73e-05	0.000274	CcSEcCtD
Diazepam—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.69e-05	0.0017	CbGpPWpGaD
Diazepam—Diarrhoea—Betamethasone—psoriasis	6.69e-05	0.000272	CcSEcCtD
Diazepam—Diarrhoea—Dexamethasone—psoriasis	6.69e-05	0.000272	CcSEcCtD
Diazepam—Hypotension—Methotrexate—psoriasis	6.65e-05	0.000271	CcSEcCtD
Diazepam—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	6.64e-05	0.00169	CbGpPWpGaD
Diazepam—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.6e-05	0.00168	CbGpPWpGaD
Diazepam—Musculoskeletal discomfort—Methotrexate—psoriasis	6.48e-05	0.000264	CcSEcCtD
Diazepam—Dizziness—Dexamethasone—psoriasis	6.46e-05	0.000263	CcSEcCtD
Diazepam—Dizziness—Betamethasone—psoriasis	6.46e-05	0.000263	CcSEcCtD
Diazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.45e-05	0.00164	CbGpPWpGaD
Diazepam—Insomnia—Methotrexate—psoriasis	6.43e-05	0.000262	CcSEcCtD
Diazepam—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.42e-05	0.00163	CbGpPWpGaD
Diazepam—Nausea—Triamcinolone—psoriasis	6.4e-05	0.000261	CcSEcCtD
Diazepam—Paraesthesia—Methotrexate—psoriasis	6.39e-05	0.00026	CcSEcCtD
Diazepam—ALB—Selenium Micronutrient Network—CAT—psoriasis	6.36e-05	0.00162	CbGpPWpGaD
Diazepam—ALB—Folate Metabolism—CRP—psoriasis	6.36e-05	0.00162	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.34e-05	0.00161	CbGpPWpGaD
Diazepam—Dyspnoea—Methotrexate—psoriasis	6.34e-05	0.000258	CcSEcCtD
Diazepam—GABRB3—BDNF signaling pathway—NFKBIA—psoriasis	6.32e-05	0.00161	CbGpPWpGaD
Diazepam—Somnolence—Methotrexate—psoriasis	6.32e-05	0.000258	CcSEcCtD
Diazepam—Hypersensitivity—Prednisone—psoriasis	6.27e-05	0.000255	CcSEcCtD
Diazepam—Dyspepsia—Methotrexate—psoriasis	6.26e-05	0.000255	CcSEcCtD
Diazepam—Vomiting—Betamethasone—psoriasis	6.21e-05	0.000253	CcSEcCtD
Diazepam—Vomiting—Dexamethasone—psoriasis	6.21e-05	0.000253	CcSEcCtD
Diazepam—Decreased appetite—Methotrexate—psoriasis	6.18e-05	0.000252	CcSEcCtD
Diazepam—Rash—Dexamethasone—psoriasis	6.16e-05	0.000251	CcSEcCtD
Diazepam—Rash—Betamethasone—psoriasis	6.16e-05	0.000251	CcSEcCtD
Diazepam—Dermatitis—Dexamethasone—psoriasis	6.16e-05	0.000251	CcSEcCtD
Diazepam—Dermatitis—Betamethasone—psoriasis	6.16e-05	0.000251	CcSEcCtD
Diazepam—Gastrointestinal disorder—Methotrexate—psoriasis	6.14e-05	0.00025	CcSEcCtD
Diazepam—Fatigue—Methotrexate—psoriasis	6.13e-05	0.00025	CcSEcCtD
Diazepam—Headache—Betamethasone—psoriasis	6.12e-05	0.000249	CcSEcCtD
Diazepam—Headache—Dexamethasone—psoriasis	6.12e-05	0.000249	CcSEcCtD
Diazepam—Asthenia—Prednisone—psoriasis	6.11e-05	0.000249	CcSEcCtD
Diazepam—Pain—Methotrexate—psoriasis	6.08e-05	0.000248	CcSEcCtD
Diazepam—CYP2C18—Metabolism—NDUFA5—psoriasis	6.02e-05	0.00153	CbGpPWpGaD
Diazepam—Pruritus—Prednisone—psoriasis	6.02e-05	0.000245	CcSEcCtD
Diazepam—GABRG3—Transmembrane transport of small molecules—CP—psoriasis	6.01e-05	0.00153	CbGpPWpGaD
Diazepam—GABRB1—Transmembrane transport of small molecules—CP—psoriasis	5.92e-05	0.00151	CbGpPWpGaD
Diazepam—Feeling abnormal—Methotrexate—psoriasis	5.86e-05	0.000239	CcSEcCtD
Diazepam—ALB—Folate Metabolism—ICAM1—psoriasis	5.85e-05	0.00149	CbGpPWpGaD
Diazepam—Diarrhoea—Prednisone—psoriasis	5.82e-05	0.000237	CcSEcCtD
Diazepam—Gastrointestinal pain—Methotrexate—psoriasis	5.82e-05	0.000237	CcSEcCtD
Diazepam—Nausea—Dexamethasone—psoriasis	5.8e-05	0.000236	CcSEcCtD
Diazepam—Nausea—Betamethasone—psoriasis	5.8e-05	0.000236	CcSEcCtD
Diazepam—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.77e-05	0.00147	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—IL10—psoriasis	5.74e-05	0.00146	CbGpPWpGaD
Diazepam—GABRG3—Transmembrane transport of small molecules—CARM1—psoriasis	5.74e-05	0.00146	CbGpPWpGaD
Diazepam—GABRB1—Transmembrane transport of small molecules—CARM1—psoriasis	5.65e-05	0.00144	CbGpPWpGaD
Diazepam—Urticaria—Methotrexate—psoriasis	5.65e-05	0.00023	CcSEcCtD
Diazepam—Dizziness—Prednisone—psoriasis	5.63e-05	0.000229	CcSEcCtD
Diazepam—Abdominal pain—Methotrexate—psoriasis	5.62e-05	0.000229	CcSEcCtD
Diazepam—ABCB1—Allograft Rejection—IL4—psoriasis	5.58e-05	0.00142	CbGpPWpGaD
Diazepam—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	5.5e-05	0.0014	CbGpPWpGaD
Diazepam—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	5.47e-05	0.00139	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.46e-05	0.00139	CbGpPWpGaD
Diazepam—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.45e-05	0.00139	CbGpPWpGaD
Diazepam—Vomiting—Prednisone—psoriasis	5.41e-05	0.00022	CcSEcCtD
Diazepam—Rash—Prednisone—psoriasis	5.37e-05	0.000219	CcSEcCtD
Diazepam—Dermatitis—Prednisone—psoriasis	5.36e-05	0.000218	CcSEcCtD
Diazepam—Headache—Prednisone—psoriasis	5.33e-05	0.000217	CcSEcCtD
Diazepam—Hypersensitivity—Methotrexate—psoriasis	5.24e-05	0.000213	CcSEcCtD
Diazepam—CYP2C18—Metabolism—CYP2S1—psoriasis	5.12e-05	0.0013	CbGpPWpGaD
Diazepam—Asthenia—Methotrexate—psoriasis	5.1e-05	0.000208	CcSEcCtD
Diazepam—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.08e-05	0.00129	CbGpPWpGaD
Diazepam—GABRB2—Transmembrane transport of small molecules—CP—psoriasis	5.06e-05	0.00129	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.06e-05	0.00129	CbGpPWpGaD
Diazepam—Nausea—Prednisone—psoriasis	5.05e-05	0.000206	CcSEcCtD
Diazepam—ALB—Selenium Micronutrient Network—CRP—psoriasis	5.05e-05	0.00128	CbGpPWpGaD
Diazepam—Pruritus—Methotrexate—psoriasis	5.03e-05	0.000205	CcSEcCtD
Diazepam—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	5e-05	0.00127	CbGpPWpGaD
Diazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.98e-05	0.00126	CbGpPWpGaD
Diazepam—GABRA5—Transmembrane transport of small molecules—CP—psoriasis	4.92e-05	0.00125	CbGpPWpGaD
Diazepam—Diarrhoea—Methotrexate—psoriasis	4.87e-05	0.000198	CcSEcCtD
Diazepam—GABRA3—Transmembrane transport of small molecules—CP—psoriasis	4.83e-05	0.00123	CbGpPWpGaD
Diazepam—GABRB2—Transmembrane transport of small molecules—CARM1—psoriasis	4.83e-05	0.00123	CbGpPWpGaD
Diazepam—GABRA2—Transmembrane transport of small molecules—CP—psoriasis	4.75e-05	0.00121	CbGpPWpGaD
Diazepam—GABRB3—Transmembrane transport of small molecules—CP—psoriasis	4.71e-05	0.0012	CbGpPWpGaD
Diazepam—Dizziness—Methotrexate—psoriasis	4.7e-05	0.000192	CcSEcCtD
Diazepam—GABRA5—Transmembrane transport of small molecules—CARM1—psoriasis	4.69e-05	0.00119	CbGpPWpGaD
Diazepam—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	4.64e-05	0.00118	CbGpPWpGaD
Diazepam—GABRG2—Transmembrane transport of small molecules—CP—psoriasis	4.63e-05	0.00118	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.62e-05	0.00118	CbGpPWpGaD
Diazepam—GABRA3—Transmembrane transport of small molecules—CARM1—psoriasis	4.61e-05	0.00117	CbGpPWpGaD
Diazepam—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	4.58e-05	0.00116	CbGpPWpGaD
Diazepam—ALB—SLC-mediated transmembrane transport—CP—psoriasis	4.56e-05	0.00116	CbGpPWpGaD
Diazepam—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	4.55e-05	0.00116	CbGpPWpGaD
Diazepam—GABRA2—Transmembrane transport of small molecules—CARM1—psoriasis	4.53e-05	0.00115	CbGpPWpGaD
Diazepam—Vomiting—Methotrexate—psoriasis	4.52e-05	0.000184	CcSEcCtD
Diazepam—GABRB3—Transmembrane transport of small molecules—CARM1—psoriasis	4.5e-05	0.00114	CbGpPWpGaD
Diazepam—Rash—Methotrexate—psoriasis	4.48e-05	0.000183	CcSEcCtD
Diazepam—Dermatitis—Methotrexate—psoriasis	4.48e-05	0.000182	CcSEcCtD
Diazepam—Headache—Methotrexate—psoriasis	4.46e-05	0.000181	CcSEcCtD
Diazepam—ALB—Folate Metabolism—IFNG—psoriasis	4.45e-05	0.00113	CbGpPWpGaD
Diazepam—GABRG2—Transmembrane transport of small molecules—CARM1—psoriasis	4.42e-05	0.00112	CbGpPWpGaD
Diazepam—Nausea—Methotrexate—psoriasis	4.22e-05	0.000172	CcSEcCtD
Diazepam—GABRB3—BDNF signaling pathway—JUN—psoriasis	4.19e-05	0.00107	CbGpPWpGaD
Diazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.15e-05	0.00106	CbGpPWpGaD
Diazepam—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	4.05e-05	0.00103	CbGpPWpGaD
Diazepam—GABRB3—BDNF signaling pathway—NFKB1—psoriasis	4.04e-05	0.00103	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—NDUFA5—psoriasis	4e-05	0.00102	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—NDUFA5—psoriasis	3.88e-05	0.000987	CbGpPWpGaD
Diazepam—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	3.86e-05	0.000982	CbGpPWpGaD
Diazepam—ALB—Folate Metabolism—NFKB1—psoriasis	3.7e-05	0.000941	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.63e-05	0.000923	CbGpPWpGaD
Diazepam—GABRB3—BDNF signaling pathway—STAT3—psoriasis	3.63e-05	0.000922	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.62e-05	0.00092	CbGpPWpGaD
Diazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.59e-05	0.000913	CbGpPWpGaD
Diazepam—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	3.56e-05	0.000905	CbGpPWpGaD
Diazepam—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.54e-05	0.0009	CbGpPWpGaD
Diazepam—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.53e-05	0.000898	CbGpPWpGaD
Diazepam—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.46e-05	0.000879	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—CYP2S1—psoriasis	3.4e-05	0.000866	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—IFNG—psoriasis	3.38e-05	0.000858	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	3.38e-05	0.000858	CbGpPWpGaD
Diazepam—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.37e-05	0.000857	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—CYP2S1—psoriasis	3.3e-05	0.000839	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.25e-05	0.000826	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.14e-05	0.000798	CbGpPWpGaD
Diazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.14e-05	0.000797	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—NDUFA5—psoriasis	2.96e-05	0.000753	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.95e-05	0.00075	CbGpPWpGaD
Diazepam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.94e-05	0.000748	CbGpPWpGaD
Diazepam—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.94e-05	0.000748	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—NDUFA5—psoriasis	2.9e-05	0.000737	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—NDUFA5—psoriasis	2.89e-05	0.000736	CbGpPWpGaD
Diazepam—ALB—Platelet degranulation—VEGFA—psoriasis	2.88e-05	0.000732	CbGpPWpGaD
Diazepam—ALB—Folate Metabolism—TNF—psoriasis	2.88e-05	0.000732	CbGpPWpGaD
Diazepam—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	2.87e-05	0.000731	CbGpPWpGaD
Diazepam—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.86e-05	0.000726	CbGpPWpGaD
Diazepam—ALB—Hemostasis—ITGAL—psoriasis	2.77e-05	0.000705	CbGpPWpGaD
Diazepam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.74e-05	0.000698	CbGpPWpGaD
Diazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.69e-05	0.000683	CbGpPWpGaD
Diazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.69e-05	0.000683	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.59e-05	0.000657	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.55e-05	0.000648	CbGpPWpGaD
Diazepam—ALB—Folate Metabolism—TP53—psoriasis	2.54e-05	0.000645	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	2.53e-05	0.000643	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—CYP2S1—psoriasis	2.52e-05	0.00064	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—NDUFA5—psoriasis	2.51e-05	0.000637	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—CARM1—psoriasis	2.5e-05	0.000636	CbGpPWpGaD
Diazepam—ALB—Metabolism—NDUFA5—psoriasis	2.49e-05	0.000634	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CYP2S1—psoriasis	2.47e-05	0.000627	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CYP2S1—psoriasis	2.46e-05	0.000626	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.34e-05	0.000594	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.32e-05	0.000591	CbGpPWpGaD
Diazepam—ALB—Folate Metabolism—IL6—psoriasis	2.32e-05	0.000591	CbGpPWpGaD
Diazepam—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.32e-05	0.000589	CbGpPWpGaD
Diazepam—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.29e-05	0.000582	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—NDUFA5—psoriasis	2.24e-05	0.000569	CbGpPWpGaD
Diazepam—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.21e-05	0.000562	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—TNF—psoriasis	2.18e-05	0.000555	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—NDUFA5—psoriasis	2.18e-05	0.000555	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.17e-05	0.000552	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CYP2S1—psoriasis	2.13e-05	0.000542	CbGpPWpGaD
Diazepam—ALB—Metabolism—CYP2S1—psoriasis	2.12e-05	0.000539	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.09e-05	0.00053	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—NDUFA5—psoriasis	2.04e-05	0.000519	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	2.04e-05	0.000519	CbGpPWpGaD
Diazepam—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.03e-05	0.000516	CbGpPWpGaD
Diazepam—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.94e-05	0.000492	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CYP2S1—psoriasis	1.9e-05	0.000484	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.9e-05	0.000484	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CYP2S1—psoriasis	1.86e-05	0.000472	CbGpPWpGaD
Diazepam—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.85e-05	0.000469	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—NDUFA5—psoriasis	1.74e-05	0.000443	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CYP2S1—psoriasis	1.73e-05	0.000441	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.73e-05	0.00044	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—CARM1—psoriasis	1.66e-05	0.000423	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.63e-05	0.000413	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—CARM1—psoriasis	1.61e-05	0.00041	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—CAT—psoriasis	1.54e-05	0.000391	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.51e-05	0.000383	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CYP2S1—psoriasis	1.48e-05	0.000377	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.44e-05	0.000366	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.39e-05	0.000352	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—NDUFA5—psoriasis	1.35e-05	0.000342	CbGpPWpGaD
Diazepam—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.28e-05	0.000325	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.26e-05	0.00032	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—CARM1—psoriasis	1.23e-05	0.000313	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CARM1—psoriasis	1.2e-05	0.000306	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CARM1—psoriasis	1.2e-05	0.000306	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—APOE—psoriasis	1.2e-05	0.000304	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CYP2S1—psoriasis	1.14e-05	0.000291	CbGpPWpGaD
Diazepam—ALB—Hemostasis—NOS2—psoriasis	1.14e-05	0.000289	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.12e-05	0.000284	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.11e-05	0.000282	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.08e-05	0.000274	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PPARG—psoriasis	1.04e-05	0.000265	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CARM1—psoriasis	1.04e-05	0.000265	CbGpPWpGaD
Diazepam—ALB—Metabolism—CARM1—psoriasis	1.04e-05	0.000263	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—CAT—psoriasis	1.02e-05	0.00026	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.97e-06	0.000254	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—CAT—psoriasis	9.91e-06	0.000252	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.73e-06	0.000247	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.68e-06	0.000246	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	9.51e-06	0.000242	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CARM1—psoriasis	9.29e-06	0.000236	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.09e-06	0.000231	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CARM1—psoriasis	9.07e-06	0.000231	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.69e-06	0.000221	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CARM1—psoriasis	8.47e-06	0.000215	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—APOE—psoriasis	7.95e-06	0.000202	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.92e-06	0.000201	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.77e-06	0.000198	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—APOE—psoriasis	7.7e-06	0.000196	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—CAT—psoriasis	7.56e-06	0.000192	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CAT—psoriasis	7.41e-06	0.000188	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CAT—psoriasis	7.39e-06	0.000188	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CARM1—psoriasis	7.24e-06	0.000184	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PPARG—psoriasis	6.92e-06	0.000176	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.77e-06	0.000172	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PPARG—psoriasis	6.71e-06	0.000171	CbGpPWpGaD
Diazepam—ALB—Hemostasis—VEGFA—psoriasis	6.59e-06	0.000167	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CAT—psoriasis	6.4e-06	0.000163	CbGpPWpGaD
Diazepam—ALB—Metabolism—CAT—psoriasis	6.37e-06	0.000162	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—APOE—psoriasis	5.88e-06	0.000149	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—APOE—psoriasis	5.76e-06	0.000146	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—APOE—psoriasis	5.74e-06	0.000146	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CAT—psoriasis	5.72e-06	0.000145	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CARM1—psoriasis	5.59e-06	0.000142	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CAT—psoriasis	5.58e-06	0.000142	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CAT—psoriasis	5.21e-06	0.000132	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PPARG—psoriasis	5.12e-06	0.00013	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PPARG—psoriasis	5.01e-06	0.000127	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PPARG—psoriasis	5e-06	0.000127	CbGpPWpGaD
Diazepam—ALB—Hemostasis—TP53—psoriasis	4.98e-06	0.000127	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—APOE—psoriasis	4.98e-06	0.000126	CbGpPWpGaD
Diazepam—ALB—Metabolism—APOE—psoriasis	4.95e-06	0.000126	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CAT—psoriasis	4.45e-06	0.000113	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—APOE—psoriasis	4.44e-06	0.000113	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—APOE—psoriasis	4.33e-06	0.00011	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PPARG—psoriasis	4.33e-06	0.00011	CbGpPWpGaD
Diazepam—ALB—Metabolism—PPARG—psoriasis	4.31e-06	0.00011	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—APOE—psoriasis	4.05e-06	0.000103	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PPARG—psoriasis	3.87e-06	9.83e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PPARG—psoriasis	3.78e-06	9.6e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PPARG—psoriasis	3.53e-06	8.97e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—APOE—psoriasis	3.46e-06	8.8e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CAT—psoriasis	3.44e-06	8.74e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PPARG—psoriasis	3.01e-06	7.66e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—APOE—psoriasis	2.67e-06	6.79e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PPARG—psoriasis	2.33e-06	5.91e-05	CbGpPWpGaD
